Download the Webinar Today
In pharmaceutical development, where most therapies never reach the market, early and strategic data investments can make all the difference. Teams are often challenged by minimal budgets and limited visibility into the real-world treatment landscape – especially in therapeutic areas where the organization has limited prior experience or knowledge.
In this webinar, experts share how their team transformed early development by using claims data to reduce risk, uncover real-world treatment dynamics, and improve evidence generation ahead of launch. You’ll hear how they shifted from data scarcity to insight-driven decision making – improving alignment across clinical, medical, and commercial functions.
Key takeaways include:
- How they modernized early-stage evidence generation with real-world claims data
- Strategies for securing budget and cross-functional buy-in
- Practical “levers for success” you can apply within your own teams
Presenters:
Jamie Drenocky
Director, US Speciality, New Product Strategy at GSK
With over 25 years of experience in pharmaceutical sales and marketing, Jamie plays a vital role in guiding pipeline assets within GSK's specialty division. She focuses on converting essential insights from the US market into commercial strategies that influence global valuations.
Chris Bell
Senior Director, US Specialty, Value Evidence & Outcomes at GSK
Health economics and outcomes research (HEOR) professional with 20+ years of experience in the pharmaceutical and healthcare consulting industries. In his current role, Chris provides strategic insights into evidence generation initiatives for GSK’s specialty pipeline, including ‘traditional’ HEOR activities (burden/cost of illness, economic modeling, real-world effectiveness) as well as the strategic use of real-world data / evidence to inform organizational decisions throughout clinical development.
Sheila Natarajan
Director, Real World Analytics at GSK
With 20 years of experience in analytics across various domains in the pharmaceutical industry, Sheila brings an integrated approach to enable data informed decisions. Her passion is to advance the use of Real- World Data to amplify patient centricity.
Matt Weinreb
VP Sales, Life Science at PurpleLab
Matt brings 20 years of experience in pharmaceuticals, biotech, and healthcare data. Before joining PurpleLab, he drove strategic partnerships at Komodo Health, delivering tailored solutions. His expertise includes commercial launch strategies, go-to-market initiatives, and commercial insights.